![](/img/cover-not-exists.png)
T10Osteonecrosis of jaw (ONJ) after antiresorptive treatment (bisphosphonates, denosumab) of cancer-treatment induced bone loss (CTIBL): a negligible risk?
Gambino, A, Cabras, M, Fusco, V, Bertetto, O, De Martino, I, Alessio, M, Numico, GVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx436.009
Date:
October, 2017
File:
PDF, 54 KB
english, 2017